Table 2 Baseline characteristics of those aged 65-80, by treatment: age, sex, race, height, weight, BMI and medication use.
| Â | Â | Â | All | First randomization | Second randomization | ||
|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | PRM | Placebo | PRM | Placebo |
| Â | Â | N | 281 | 137 | 144 | 198 | 75 |
Characteristic | Visit | Â | Â | Â | Â | Â | Â |
Age (years) | 1 | Mean (SD) | 71.0 (4.1) | 71.1 (3.8) | 70.9 (4.4) | 70.9 (3.9) | 70.9 (4.4) |
Sex | Â | N (%) female | 182 (64.8%) | 89 (65.0%) | 93 (64.6%) | 128 (64.6%) | 50 (66.7%) |
Race* | Â | N (%) white | 280 (100.0%) | 137 (100.0%) | 143 (100.0%) | 198 (100.0%) | 74 (100.0%) |
Height (m) | 1 | Mean (SD) | 1.65 (0.09) | 1.65 (0.09) | 1.64 (0.09) | 1.65 (0.09) | 1.64 (0.09) |
Weight (kg) | 1 | Mean (SD) | 73.3 (13.0) | 73.1 (14.1) | 73.6 (11.8) | 73.2 (13.2) | 74.1 (12.6) |
BMI (kg/m2) | 1 | Mean (SD) | 27.0 (3.8) | 26.8 (3.6) | 27.3 (3.9) | 26.8 (3.6) | 27.7 (4.2) |
Taking any medications | 1 | N (%) | 265 (94.3%) | 130 (94.9%) | 135 (93.8%) | 187 (94.4%) | 70 (93.3%) |
Taking codeine†| 1 | N (%) | 73 (26.2%) | 35 (25.7%) | 38 (26.6%) | 50 (25.5%) | 20 (26.7%) |
Taking codeine | 2 | N (%) | 58 (20.6%) | 28 (20.4%) | 30 (20.8%) | 40 (20.2%) | 16 (21.3%) |
Confirmed codeine analgesic | 2 | N (%) | 43 (15.3%) | 18 (13.1%) | 25 (17.4%) | 25 (12.6%) | 16 (21.3%) |